1391 related articles for article (PubMed ID: 8426084)
1. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
[TBL] [Abstract][Full Text] [Related]
2. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
Mombelli G; Monotti R; Haeberli A; Straub PW
Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
[TBL] [Abstract][Full Text] [Related]
3. Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients.
Cioni G; Cristani A; Mussini C; Grandi S; Pentore R; Zeneroli ML; Tizzanini W; Zagni G; Ventura E
Ital J Gastroenterol; 1990 Apr; 22(2):70-4. PubMed ID: 2131934
[TBL] [Abstract][Full Text] [Related]
4. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of several parameters of coagulation in liver cirrhosis: disseminated intravascular coagulation or pseudo-disseminated intravascular coagulation?].
Petrella V; Parachini F; Rigotti T; Galimberti M; Cusumano S
Minerva Med; 1988 Mar; 79(3):193-8. PubMed ID: 3362400
[TBL] [Abstract][Full Text] [Related]
6. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
Murakoshi T
Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
[TBL] [Abstract][Full Text] [Related]
7. [Differential determination of fibrinogen degradation products in assessment of the stages of plasma consumption in patients with infection and liver cirrhosis].
Raschka C; Róka L
Leber Magen Darm; 1993 Jan; 23(1):31-4. PubMed ID: 8445974
[TBL] [Abstract][Full Text] [Related]
8. High D-dimer levels: a possible index of risk of overt disseminated intravascular coagulation and/or digestive bleeding in advanced liver cirrhosis?
Cioni G; Cristani A; Vignoli A; Ventura E
Recenti Prog Med; 1994 Apr; 85(4):230-4. PubMed ID: 8016448
[TBL] [Abstract][Full Text] [Related]
9. [A proposed method for the laboratory diagnosis of disseminated intravascular coagulation in liver cirrhosis].
Cristani A; Cioni G; Mussini C; Pentore R; Zagni G; Ventura E
Recenti Prog Med; 1990 May; 81(5):322-4. PubMed ID: 2377810
[TBL] [Abstract][Full Text] [Related]
10. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen survival and fibrinopeptide A in acute leukemia.
Castaman G; Galloni E; Dri AV; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
[TBL] [Abstract][Full Text] [Related]
12. Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus.
Cronlund M; Hardin J; Burton J; Lee L; Haber E; Bloch KJ
J Clin Invest; 1976 Jul; 58(1):142-51. PubMed ID: 932202
[TBL] [Abstract][Full Text] [Related]
13. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
14. [The incidence of consumption coagulopathy in liver cirrhosis].
Moreno Abadía V; Bermúdez García JM; Maldonado Martín A; Rico Irles J
An Med Interna; 1989 Sep; 6(9):466-71. PubMed ID: 2562720
[TBL] [Abstract][Full Text] [Related]
15. [The effect of liver cirrhosis on activation of the coagulation and fibrinolysis system and on coagulation inhibitors].
Zurborn KH; Gram J; Rohwedder E; Bewig B; Bruhn HD
Med Klin (Munich); 1989 Nov; 84(11):515-8. PubMed ID: 2593977
[TBL] [Abstract][Full Text] [Related]
16. alpha 2 Antiplasmin and disseminated intravascular coagulation in liver cirrhosis.
Marongiu F; Mamusa AM; Mameli G; Mulas G; Solinas A; Demelia L; Contu L
Thromb Res; 1985 Jan; 37(2):287-94. PubMed ID: 3975873
[TBL] [Abstract][Full Text] [Related]
17. Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis.
Kim SY; Kim JE; Kim HK; Kim I; Yoon SS; Park S
Blood Coagul Fibrinolysis; 2013 Mar; 24(2):150-6. PubMed ID: 23314386
[TBL] [Abstract][Full Text] [Related]
18. [Intravascular coagulation of the blood in liver cirrhosis (a review of the literature)].
Shelest LIu; Sushko EA; Shkapko VD; Shekhter IE; Ena IaM
Vrach Delo; 1990 Aug; (8):44-7. PubMed ID: 2256285
[No Abstract] [Full Text] [Related]
19. Fibrinopeptide A in urine from patients with venous thromboembolism, disseminated intravascular coagulation and rheumatoid arthritis--evidence for dephosphorylation and carboxyterminal degradation of the peptide by the kidney.
Leeksma OC; Meijer-Huizinga F; Stoepman-van Dalen EA; van Aken WG; van Mourik JA
Thromb Haemost; 1985 Dec; 54(4):792-8. PubMed ID: 4089813
[TBL] [Abstract][Full Text] [Related]
20. [Circulating levels of products of fibrinogen and fibrin monomer degradation in liver cirrhosis].
Rocha E; López Borrasca A
Rev Med Univ Navarra; 1974; 18(3-4):143-7. PubMed ID: 4471076
[No Abstract] [Full Text] [Related]
[Next] [New Search]
